Welgene Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 10, 2020 at 10:58 am
Share
Welgene Biotech Co.,Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 193.360 million compared to TWD 159.957 million a year ago. Operating income was TWD 15.818 million compared to TWD 10.125 million a year ago. Net income was TWD 11.134 million compared to TWD 7.893 million a year ago. Basic earnings per share was TWD 0.54 compared to TWD 0.38 a year ago. Diluted earnings per share was TWD 0.53 compared to TWD 0.38 a year ago.
WELGENE BIOTECH CO., LTD. is a Taiwan-based company mainly engaged in the provision of genetic testing services and products. The company focuses on deoxyribonucleic acid (DNA) microarray, Next Generation Sequencing and real-time quantitative polymerase chain reaction (PCR) and other testing technologies, which used in school research units, hospitals and biotech companies. The Company is also engaged in the trading of medical equipment. The company mainly operates in two business segments, including Biotechnology Testing segment and Equipment Trading segment. The Company mainly operates in Taiwan market.
WELGENE BIOTECH CO.,LTD. 
